Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244.
Horspool AM, Sen-Kilic E, Malkowski AC, Breslow SL, Mateu-Borras M, Hudson MS, Nunley MA, Elliott S, Ray K, Snyder GA, Miller SJ, Kang J, Blackwood CB, Weaver KL, Witt WT, Huckaby AB, Pyles GM, Clark T, Al Qatarneh S, Lewis GK, Damron FH, Barbier M.
Horspool AM, et al. Among authors: witt wt.
Front Cell Infect Microbiol. 2023 Apr 14;13:1117844. doi: 10.3389/fcimb.2023.1117844. eCollection 2023.
Front Cell Infect Microbiol. 2023.
PMID: 37124031
Free PMC article.